Marjorie Taylor Greene Says It Is 'Awful' That 'No One Is Standing Up For Cancer Patients' After Bayer Scores Roundup Victory In Supreme Court
Key Points:
- The U.S. Supreme Court ruled 7-2 in favor of Bayer AG, limiting thousands of state lawsuits claiming that Roundup's active ingredient glyphosate causes cancer, overturning a $1.25 million jury award to a plaintiff alleging glyphosate exposure caused non-Hodgkin lymphoma.
- Former Rep. Marjorie Taylor Greene criticized both the Supreme Court and former President Donald Trump for protecting Monsanto (now Bayer) and glyphosate, arguing that no one is advocating for cancer patients affected by the herbicide.
- Bayer, which acquired Monsanto in 2018, maintains that glyphosate is not likely carcinogenic, citing EPA and global regulatory reviews, and noted that much litigation is based on a now outdated 2015 assessment by the International Agency for Research on Cancer.
- The controversy remains politically charged as Trump issued an executive order invoking the Defense Production Act to secure domestic supplies of glyphosate-based herbicides and elemental phosphorus, critical for national security and agriculture, with Bayer as the sole U.S. producer of elemental phosphorus.
- The article also highlights various investment platforms offering diversification opportunities beyond traditional stocks, including real estate, AI infrastructure, robotics, precious metals, and alternative assets.